Cargando…

Commentary: Evaluation of Models of Parkinson's Disease

Detalles Bibliográficos
Autores principales:	Leal, Pollyana C., Lins, Lívia C. R. F., de Gois, Auderlan M., Marchioro, Murilo, Santos, José R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914559/ https://www.ncbi.nlm.nih.gov/pubmed/27444376 http://dx.doi.org/10.3389/fnins.2016.00283

Ejemplares similares

Commentary: Adenosine A(2A) Receptor Blockade Prevents Rotenone-Induced Motor Impairment in a Rat Model of Parkinsonism
por: de Souza, Marina F., et al.
Publicado: (2017)

Commentary: Evaluation of Models of Parkinson's Disease
por: Muñoz, Patricia, et al.
Publicado: (2016)

Corrigendum: Commentary: Evaluation of Models of Parkinson's Disease
por: Muñoz, Patricia, et al.
Publicado: (2016)

Depressant effect of geraniol on the central nervous system of rats: Behavior and ECoG power spectra
por: Medeiros, Katty Anne A.L., et al.
Publicado: (2018)

Evaluation of Models of Parkinson's Disease
por: Jagmag, Shail A., et al.
Publicado: (2016)

Nutritional status, oxidative stress and dementia: the role of selenium in Alzheimer's disease
por: Santos, Jose R., et al.
Publicado: (2014)

Commentary: Parkinson's Disease Genes VPS35 and EIF4G1 Interact Genetically and Converge on α-Synuclein
por: Olszewska, Diana A., et al.
Publicado: (2016)

Commentary: Autism: A model of neurodevelopmental diversity informed by genomics
por: Sarovic, Darko
Publicado: (2023)

Commentary: Contextualizing Neuroticism in the Hierarchical Taxonomy of Psychopathology
por: Jeronimus, Bertus F.
Publicado: (2020)

microRNAs: Emerging Targets Regulating Oxidative Stress in the Models of Parkinson's Disease
por: Xie, Yangmei, et al.
Publicado: (2016)

Commentary: Neural Changes Associated with Treatment Outcome in Children with Externalizing Problems
por: Rice, Timothy R.
Publicado: (2016)

Commentary: Mind-Wandering Changes in Dysphoria
por: Fell, Juergen, et al.
Publicado: (2021)

Commentary: Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence)
por: Nelson, Barnaby, et al.
Publicado: (2020)

Differential impact of resilience on demoralization and depression in Parkinson disease
por: de Figueiredo, John M., et al.
Publicado: (2023)

Response to: Commentary: Sex Differences in the Peripheral Immune System in Patients with Depression
por: Birur, Badari, et al.
Publicado: (2017)

The Psychobiological Problems of Continued Nicotine Dependency in E-Cigarette ‘Vapers’. Commentary: “Electronic Cigarettes”
por: Parrott, Andrew C.
Publicado: (2015)

Parkinson's Disease and Neurodegeneration: GABA-Collapse Hypothesis
por: Błaszczyk, Janusz W.
Publicado: (2016)

Neuropsychiatric Symptoms in Parkinson’s Disease: Beyond Complications
por: Kehagia, Angie A.
Publicado: (2016)

Vortioxetine Improved Depressive State In Parkinson’s Disease
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Commentary: Psychedelic Psychiatry's Brave New World
por: Nobile, Bénédicte, et al.
Publicado: (2020)

Alpha-synuclein Toxicity in the Early Secretory Pathway: How It Drives Neurodegeneration in Parkinsons Disease
por: Wang, Ting, et al.
Publicado: (2015)

Commentary: Serum Biomarkers Are Potential Diagnosis and Treatment Targets for Depressive Symptoms in Patients With Cardiovascular Diseases
por: Liu, Cunming, et al.
Publicado: (2021)

From Perceived Stress to Demoralization in Parkinson Disease: A Path Analysis
por: de Figueiredo, John M., et al.
Publicado: (2022)

A Tangled Web – Tau and Sporadic Parkinson's Disease
por: Wray, Selina, et al.
Publicado: (2010)

Potential application of lithium in Parkinson's and other neurodegenerative diseases
por: Lazzara, Carol A., et al.
Publicado: (2015)

The Genetic Basis of Cognitive Impairment and Dementia in Parkinson’s Disease
por: Collins, Lucy M., et al.
Publicado: (2016)

Damaged Insula Network Contributes to Depression in Parkinson’s Disease
por: Huang, Peiyu, et al.
Publicado: (2020)

Stigma and Associated Correlates of Elderly Patients With Parkinson's Disease
por: Hou, Miaomiao, et al.
Publicado: (2021)

A Commentary on “A New Initiative on Precision Medicine”
por: Ghitza, Udi E.
Publicado: (2015)

Commentary: The Impact of Neuroimmune Alterations in Autism Spectrum Disorder
por: Siniscalco, Dario
Publicado: (2015)

The Puzzling Unidimensionality of the DSM Substance Use Disorders: Commentary
por: Martin, Christopher Stephen
Publicado: (2013)

Commentary: A Neural Basis for the Acquired Capacity for Suicide
por: Gonda, Xenia
Publicado: (2017)

A Comparison of Treatment-Seeking Behavioral Addiction Patients with and without Parkinson’s Disease
por: Sauvaget, Anne, et al.
Publicado: (2017)

A New Viewpoint on the Etiopathogenesis of Depression: Insights From the Neurophysiology of Deep Brain Stimulation in Parkinson's Disease and Treatment-Resistant Depression
por: Silva-dos-Santos, Amílcar, et al.
Publicado: (2021)

Parkinson's Disease: Impulsivity Does Not Cause Impulse Control Disorders but Boosts Their Severity
por: Marín-Lahoz, Juan, et al.
Publicado: (2018)

Biopsable Neural Tissues: Toward New Biomarkers for Parkinson's Disease?
por: Lebouvier, Thibaud, et al.
Publicado: (2010)

An Investigation on the Clinical Features and Neurochemical Changes in Parkinson's Disease With Depression
por: Lian, Teng-Hong, et al.
Publicado: (2019)

Commentary: Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA
por: Ruan, Xiulu, et al.
Publicado: (2017)

Commentary: Physical Functional Capacity and C-Reactive Protein in Schizophrenia
por: Elliesen, Ruth, et al.
Publicado: (2018)

Commentary: Sex Differences in the Peripheral Immune System in Patients with Depression
por: Breidenstein, Jonas, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m1d4dldghdheuan6c7kvd5baod